• OPEN AN ACCOUNT
Indian Indices
Nifty
25,509.70 -87.95
(-0.34%)
Sensex
83,311.01 -148.14
( -0.18%)
Bank Nifty
57,554.25 -272.80
( -0.47%)
Nifty IT
35,337.60 63.05
( 0.18%)
Global Indices
Nasdaq
46,931.02 -400.98
(-0.85%)
Dow Jones
6,741.06 -76.23
(-1.12%)
Hang Seng
50,848.14 635.87
(1.27%)
Nikkei 225
9,736.38 -40.70
(-0.42%)
Forex
USD-INR
88.68 -0.07
(-0.08%)
EUR-INR
101.96 -0.30
(-0.29%)
GBP-INR
115.92 -0.66
(-0.56%)
JPY-INR
0.58 0.00
(0.22%)

EQUITY - MARKET SCREENER

Genpharmasec Ltd
Industry :  Trading
BSE Code
ISIN Demat
Book Value()
531592
INE861N01036
1.2018693
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
25.33
84.17
EPS(TTM)
Face Value()
Div & Yield %
0.06
1
0
 

CES consolidated net profit declines 17.93% in the March 2025 quarter
May 31,2025
Net profit of CES declined 17.93% to Rs 4.44 crore in the quarter ended March 2025 as against Rs 5.41 crore during the previous quarter ended March 2024. Sales rose 14.11% to Rs 131.80 crore in the quarter ended March 2025 as against Rs 115.50 crore during the previous quarter ended March 2024.

For the full year,net profit rose 11.48% to Rs 29.52 crore in the year ended March 2025 as against Rs 26.48 crore during the previous year ended March 2024. Sales rose 11.36% to Rs 522.12 crore in the year ended March 2025 as against Rs 468.87 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales131.80115.50 14 522.12468.87 11
OPM %4.365.13 -8.428.28 -
PBDT5.666.56 -14 46.8641.52 13
PBT4.805.71 -16 43.3837.39 16
NP4.445.41 -18 29.5226.48 11